openPR Logo
Press release

Kepley BioSystems Incorporated selected as finalist in 2016 NC IDEA challenge

11-01-2016 05:35 PM CET | Science & Education

Press release from: Kepley BioSystems, Inc.

Kepley BioSystems President, Dr. Dellinger, loads OrganoBait, the synthetic alternative bait, into a crab trap.

Kepley BioSystems President, Dr. Dellinger, loads OrganoBait, the synthetic alternative bait, into a crab trap.

Greensboro, NC, November 1, 2016 -- Kepley BioSystems announced today that their team has been selected as a Top 25 finalist in the 2016 NC IDEA grant program. NC IDEA provides semi-annual grant solicitations for ideas with the potential to become high-growth companies. The grant program is a catalyst for technological breakthroughs developed in North Carolina that have a significant potential to successfully transition commercially viable high-growth enterprise. Their mission is to assist in the funding gap of top researchers and entrepreneurs through the intersection of government and private equity support. Kepley BioSystems ranked in the top 25 of all North Carolina applicants.

Kepley BioSystems has invented a patent-pending, disruptive synthetic bait with the potential to eliminate the use of forage fish as an attractant in commercial and recreation crustacean and sport fishing industries. These industries currently spends more than $20 billion annually in the global capture and utilization of 40 billion pounds of forage fish. This synthetic product, OrganoBaitTM, mimics the attractant properties of forage fish, without the use of fish or any animal byproduct. OrganoBait is sustainable, environmentally friendly, cost-effective, reliably available, and less expensive compared to traditional forage fish. Regulators and environmentalists will also have compelling reasons to support this product for it’s potential to help avert ocean ecosystem collapse from overfishing, especially using drift- net practices.

Follow Kepley BioSystems and the other 24 competitive applicants through the NC IDEA grant program on our website (kepleybiosystems.com) and at ncidea.org.

ABOUT Kepley BioSystems Inc.

Kepley BioSystems originated at the Joint School of Nanoscience and Nanoengineering (JSNN), North Carolina A&T State University and The University of North Carolina at Greensboro; the company is now located at the Gateway University Research Park proximal to JSNN. Kepley BioSystems is an academically-driven company led by Professor Christopher Kepley and Dr. Anthony Dellinger, a recent graduate, working in collaboration with lead inventor Terry E. Brady, located on the Caribbean island of Anguilla, British West Indies.

ABOUT NC IDEA

NC IDEA is a private foundation committed to supporting business innovation and economic advancement in North Carolina and serves as a catalyst for young, high- growth companies. Today, the organization fulfills this mission through four initiatives. The Ecosystem Partner Grant program funds organizations across the state that execute creative programs to support entrepreneurs. Over the last decade, the Seed Grant program has awarded over $4.5M to 109 high-growth companies across the state. Since 2011, more than 100 companies have participated in the Groundwork Labs startup program. SoarTriangle, a program founded in 2012 to address the proven funding gap for female entrepreneurs, formally became a foundation program in August 2016.

Anthony L. Dellinger, Ph.D.
President, Adjunct Researcher Kepley BioSystems Incorporated Joint School of Nanoscience & Nanoengineering
Phone: 336-217-5163
Email: adellinger@kepleybiosystems.com
Web: www.kepleybiosystems.com

https://www.facebook.com/kepleybiosystems/
https://twitter.com/organobait
https://www.linkedin.com/in/anthonydellinger

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kepley BioSystems Incorporated selected as finalist in 2016 NC IDEA challenge here

News-ID: 378089 • Views:

More Releases from Kepley BioSystems, Inc.

KePSLA joins hands with IDS Next
KePSLA joins hands with IDS Next
KePSLA and IDS NEXT have announced a partnering agreement, where KePSLA’s proprietary Business Intelligence Solutions will now be available to all IDS Next Customers. IDS will be able to provide their actionable insights on guest experience, influence marketing, online presence & reputation management to their large and marquee set of hoteliers through a single seamless experience. All customer of IDS will now work out of a single sign-on process, both
Kepley BioSystems in Top Tier at Hello Tomorrow Global Summit
Kepley BioSystems in Top Tier at Hello Tomorrow Global Summit
Tuesday, October 18, 2016, Greensboro, N.C.: Kepley BioSystems (KBI) was a finalist from among 3,500 original contestants, which narrowed to representatives of 500 deep-technology start-ups invited to participate in the third Hello Tomorrow Global Summit. The event took place last week on October 13-14, 2016, at the Le Centquatre conference center in Paris. The Global Summit, which Bloomberg News described as, “Where the brightest minds from the science-entrepreneurship ecosystem meet
Kepley BioSystems Selected as a Hello Tomorrow Challenge Finalist
Kepley BioSystems Selected as a Hello Tomorrow Challenge Finalist
Competing with 70 other extraordinary startup companies from around the world, Kepley BioSystems was named as a top finalist in the Hello Tomorrow Challenge. Originally, 3,500 companies from 105 countries had entered the competition, and recently the field was narrowed to 500 semi-finalists. Now, just 70 companies that have been invited to make presentations at the Hello Tomorrow Global Summit on October 13 and 14 in Paris, France, where they

All 4 Releases


More Releases for BioSystems

Microelectrode Arrays (MEAs) Market Size And Forecast | MaxWell Biosystems, Axio …
New Jersey, United States - The research study offers an in-depth assessment of the Microelectrode Arrays (MEAs) Market and helps market players to gain a foothold in the industry. It highlights critical market dynamics such as drivers, restraints, trends, and opportunities to help businesses prepare for the challenges ahead. It provides a regional analysis of the Microelectrode Arrays (MEAs) market to uncover major opportunities available in different parts of the
Multiplex Biomarker Imaging Market 2027 | ToposNomos Ltd, Perkin Elmer, Inc., Le …
A study on the global multiplex biomarker imaging market has been conducted by Research Report Insights during the assessment period (2017-2027). The study reveals the value forecast of the market and highlights factors influencing the growth of the market. In terms of revenues, the market will expand from approximately US$ 271 Mn in 2017 to over US$ 840 Mn by the end of 2027, riding on healthy double-digit CAGR during
Multiplex Biomarker Imaging Market 2027 | Leica Biosystems Nussloch GmbH, Thermo …
A study on the global multiplex biomarker imaging market has been conducted by Research Report Insights during the assessment period (2017-2027). The study reveals the value forecast of the market and highlights factors influencing the growth of the market. In terms of revenues, the market will expand from approximately US$ 271 Mn in 2017 to over US$ 840 Mn by the end of 2027, riding on healthy double-digit CAGR during
Mannanase Market 2017 - American Biosystems, Elanco
Apex Research, recently published a detailed market research study focused on the "Mannanase Market" across the global, regional and country level. The report provides 360° analysis of "Mannanase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Mannanase industry, and estimates the future trend of Mannanase market on the basis of
Global Biomedical Nanoscale Devices Market 2017 : Triton BioSystems, Zeptosens A …
Biomedical Nanoscale Devices A market study based on the " Biomedical Nanoscale Devices Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Biomedical Nanoscale Devices Market 2017’. The research report analyses the historical as well as present performance of the worldwide Biomedical Nanoscale Devices industry, and makes predictions on the future status of Biomedical Nanoscale Devices market on the basis of this analysis. Get Free
Global Laboratory distillation systems Market 2017 : Shanghai Sanch Medical Inst …
Laboratory distillation systems A market study based on the " Laboratory distillation systems Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Laboratory distillation systems Market 2017’. The research report analyses the historical as well as present performance of the worldwide Laboratory distillation systems industry, and makes predictions on the future status of Laboratory distillation systems market on the basis of this analysis. Get Free